logo

Alexion Pharmaceuticals Inc. (ALXN)



Trade ALXN now with
  Date
  Headline
10/23/2019 6:32:10 AM Alexion Q3 GAAP EPS $2.08, Up 41% From Prior Year
10/16/2019 6:33:14 AM Alexion To Acquire Achillion For Initial All-cash Transaction For $6.30/Shr
10/10/2019 4:14:06 PM Alexion Pharma Appoints As Tanisha Carino As EVP And Chief Corporate Affairs Officer
10/10/2019 7:35:28 AM Alexion,Stealth Announce Deal For Option To Co-Develop And Commercialize Elamipretide For Mitochondrial Diseases
7/26/2019 8:10:28 AM Alexion Gets Positive CHMP Opinion For SOLIRIS For Treatment Of NMOSD
7/24/2019 6:33:54 AM Alexion Q2 GAAP EPS $2.04; Non-GAAP EPS $2.64
6/20/2019 8:19:48 AM Alexion Pharma: FDA Accepts SBLA For ULTOMIRIS Under Priority Review For Atypical Hemolytic Uremic Syndrome
6/14/2019 6:34:59 AM Alexion Pharma Says Positive Phase 3 Extension Data For ULTOMIRIS Presented At EHA Congress
  
 
>